Current Management of Primary Immune Thrombocytopenia

Advances in Therapy - United States
doi 10.1007/s12325-015-0251-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Management of Primary Immune Thrombocytopenia, 2012: A Survey of Oklahoma Hematologists-Oncologists

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Immune Thrombocytopenia

Hospital Medicine Clinics
Medicine
2017English

Switching Thrombopoietin Receptor Agonist Treatments in Patients With Primary Immune Thrombocytopenia

Therapeutic Advances in Hematology
Hematology
2019English

A Blinded Study of Bone Marrow Examinations in Patients With Primary Immune Thrombocytopenia

European Journal of Haematology
MedicineHematology
2012English

Methylprednisolone‐induced Immune Thrombocytopenia

American Journal of Hematology
Hematology
2019English

Babesiosis-Associated Immune Thrombocytopenia

Stem Cell Investigation
2017English

Primary Immune Thrombocytopenia Responding to Antithyroid Treatment in a Patient With Graves’ Disease

Annals of Hematology
MedicineHematology
2010English

Thromboembolism in Adults With Primary Immune Thrombocytopenia: A Systematic Literature Review and Meta-Analysis

European Journal of Haematology
MedicineHematology
2016English

Immune Thrombocytopenia in Lymphoproliferative Diseases

Blood
BiochemistryImmunologyCell BiologyHematology
1979English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy